StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a hold rating on the stock.
Brooklyn ImmunoTherapeutics Stock Up 0.0 %
NYSE:BTX opened at $0.21 on Friday. The company has a market cap of $12.07 million, a P/E ratio of -0.23 and a beta of 4.61. The firm’s 50 day moving average is $1.03 and its two-hundred day moving average is $1.56. Brooklyn ImmunoTherapeutics has a fifty-two week low of $0.17 and a fifty-two week high of $10.10.
Brooklyn ImmunoTherapeutics Company Profile
Further Reading
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- Insider Buying Explained: What Investors Need to Know
- Disney’s Magic Strategy: Reinventing the House of Mouse
- Stock Sentiment Analysis: How it Works
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- Buy P&G Now, Before It Sets A New All-Time High
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
